Respironics to Webcast Fiscal 2001 Third Quarter Conference Call

Apr 18, 2001, 01:00 ET from Respironics, Inc.

    PITTSBURGH, April 18 /PRNewswire/ -- RESPIRONICS, INC. (Nasdaq:   RESP), a
 recognized resource in the medical device market, announced today that it
 intends to release its fiscal 2001 third quarter and nine months results for
 the period ending March 31, 2001 on Thursday April 26, 2001.  In conjunction
 with this release and to review the Company's quarterly results and business
 outlook, Respironics will host a conference call that will be broadcast
 simultaneously live over the Internet.
     Individuals wishing to participate on the webcast, to be held at 8:30 a.m.
 EST on Thursday April 26, 2001, can access the event at the Company's web site
 at http://www.respironics.com .
     Please allow extra time prior to the call to visit the site and download
 the streaming media software required to listen to the Internet broadcast.
 The online archive of the broadcast will be available within 2 hours of the
 live call and will be available for 30 days.
     Respironics, a recognized resource in the medical device market, provides
 innovative products and unique programs to health care providers while helping
 them to grow and manage their business efficiently.  The company's focus is on
 home care, hospital and international markets providing programs that manage
 sleep disordered breathing, chronic obstructive pulmonary disease, asthma,
 infant care and restrictive lung disorders.  Globally positioned, the company
 employs nearly 1,900 individuals worldwide and has manufacturing facilities in
 several domestic and international locations.  Further information on
 Respironics can be found on its web site: http://www.respironics.com .
     This press release contains forward-looking statements, including
 statements relating to developments in the healthcare industry, third-party
 reimbursement policies and practices, future sales and acceptance of the
 company's products and Power Program(TM), new product development and
 regulatory requirements, which are subject to change.  Actual results may
 differ materially from those described in any forward-looking statements.
 Additional information on potential factors that could affect the company's
 financial results are included in the reports filed with the SEC, including
 the reports on Form 10-K, 10-Q and 8-K. 

SOURCE Respironics, Inc.

SOURCE Respironics, Inc.
    PITTSBURGH, April 18 /PRNewswire/ -- RESPIRONICS, INC. (Nasdaq:   RESP), a
 recognized resource in the medical device market, announced today that it
 intends to release its fiscal 2001 third quarter and nine months results for
 the period ending March 31, 2001 on Thursday April 26, 2001.  In conjunction
 with this release and to review the Company's quarterly results and business
 outlook, Respironics will host a conference call that will be broadcast
 simultaneously live over the Internet.
     Individuals wishing to participate on the webcast, to be held at 8:30 a.m.
 EST on Thursday April 26, 2001, can access the event at the Company's web site
 at http://www.respironics.com .
     Please allow extra time prior to the call to visit the site and download
 the streaming media software required to listen to the Internet broadcast.
 The online archive of the broadcast will be available within 2 hours of the
 live call and will be available for 30 days.
     Respironics, a recognized resource in the medical device market, provides
 innovative products and unique programs to health care providers while helping
 them to grow and manage their business efficiently.  The company's focus is on
 home care, hospital and international markets providing programs that manage
 sleep disordered breathing, chronic obstructive pulmonary disease, asthma,
 infant care and restrictive lung disorders.  Globally positioned, the company
 employs nearly 1,900 individuals worldwide and has manufacturing facilities in
 several domestic and international locations.  Further information on
 Respironics can be found on its web site: http://www.respironics.com .
     This press release contains forward-looking statements, including
 statements relating to developments in the healthcare industry, third-party
 reimbursement policies and practices, future sales and acceptance of the
 company's products and Power Program(TM), new product development and
 regulatory requirements, which are subject to change.  Actual results may
 differ materially from those described in any forward-looking statements.
 Additional information on potential factors that could affect the company's
 financial results are included in the reports filed with the SEC, including
 the reports on Form 10-K, 10-Q and 8-K. SOURCE Respironics, Inc.
 
 SOURCE  Respironics, Inc.